173 related articles for article (PubMed ID: 28370539)
1. RARα/RXR synergism potentiates retinoid responsiveness in cutaneous T-cell lymphoma cell lines.
Wang L; DeMarco SS; Peaks MS; Maiorana-Boutilier AL; Chen J; Crouch MJ; Shewchuk BM; Shaikh SR; Phillips CM; Bridges LC
Exp Dermatol; 2017 Nov; 26(11):1004-1011. PubMed ID: 28370539
[TBL] [Abstract][Full Text] [Related]
2. Retinoids Bias Integrin Expression and Function in Cutaneous T-Cell Lymphoma.
Wang L; DeMarco SS; Chen J; Phillips CM; Bridges LC
J Invest Dermatol; 2015 Aug; 135(8):2102-2108. PubMed ID: 25826424
[TBL] [Abstract][Full Text] [Related]
3. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic Acid (NEt-TMN).
Heck MC; Wagner CE; Shahani PH; MacNeill M; Grozic A; Darwaiz T; Shimabuku M; Deans DG; Robinson NM; Salama SH; Ziller JW; Ma N; van der Vaart A; Marshall PA; Jurutka PW
J Med Chem; 2016 Oct; 59(19):8924-8940. PubMed ID: 27592633
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.
Schaier M; Liebler S; Schade K; Shimizu F; Kawachi H; Grone HJ; Chandraratna R; Ritz E; Wagner J
J Mol Med (Berl); 2004 Feb; 82(2):116-25. PubMed ID: 14712350
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.
Zhang C; Hazarika P; Ni X; Weidner DA; Duvic M
Clin Cancer Res; 2002 May; 8(5):1234-40. PubMed ID: 12006543
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
Elmazar MM; Nau H
Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
[TBL] [Abstract][Full Text] [Related]
8. Keratins 2 and 4/13 in reconstituted human skin are reciprocally regulated by retinoids binding to nuclear receptor RARalpha.
Virtanen M; Sirsjö A; Vahlquist A; Törmä H
Exp Dermatol; 2010 Jul; 19(7):674-81. PubMed ID: 20456496
[TBL] [Abstract][Full Text] [Related]
9. Modeling, synthesis and biological evaluation of potential retinoid X receptor-selective agonists: novel halogenated analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).
Furmick JK; Kaneko I; Walsh AN; Yang J; Bhogal JS; Gray GM; Baso JC; Browder DO; Prentice JL; Montano LA; Huynh CC; Marcus LM; Tsosie DG; Kwon JS; Quezada A; Reyes NM; Lemming B; Saini P; van der Vaart A; Groy TL; Marshall PA; Jurutka PW; Wagner CE
ChemMedChem; 2012 Sep; 7(9):1551-66. PubMed ID: 22927238
[TBL] [Abstract][Full Text] [Related]
10. Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma.
Querfeld C; Rosen ST; Guitart J; Rademaker A; Fung BB; Posten W; Kuzel TM
J Am Acad Dermatol; 2004 Jul; 51(1):25-32. PubMed ID: 15243520
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo.
Seguin-Devaux C; Devaux Y; Latger-Cannard V; Grosjean S; Rochette-Egly C; Zannad F; Meistelman C; Mertes PM; Longrois D
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E525-35. PubMed ID: 12169446
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
13. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway.
López-Boado YS; Klaus M; Dawson MI; López-Otín C
J Biol Chem; 1996 Dec; 271(50):32105-11. PubMed ID: 8943263
[TBL] [Abstract][Full Text] [Related]
15. Both retinoic-acid-receptor- and retinoid-X-receptor-dependent signalling pathways mediate the induction of the brown-adipose-tissue-uncoupling-protein-1 gene by retinoids.
Alvarez R; Checa M; Brun S; Viñas O; Mampel T; Iglesias R; Giralt M; Villarroya F
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):91-7. PubMed ID: 10600643
[TBL] [Abstract][Full Text] [Related]
16. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas.
Warda A; Staniszewski LJP; Sabir Z; Livingston S; Sausedo M; Reshi S; Ron E; Applegate MT; Haddad D; Khamisi M; Marshall PA; Wagner CE; Jurutka PW
Cells; 2023 Nov; 12(21):. PubMed ID: 37947652
[TBL] [Abstract][Full Text] [Related]
17. Retinoid receptors: pathways of proliferation inhibition and apoptosis induction in breast cancer cell lines.
Raffo P; Emionite L; Colucci L; Belmondo F; Moro MG; Bollag W; Toma S
Anticancer Res; 2000; 20(3A):1535-43. PubMed ID: 10928067
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids.
Hellemans K; Verbuyst P; Quartier E; Schuit F; Rombouts K; Chandraratna RA; Schuppan D; Geerts A
Hepatology; 2004 Jan; 39(1):97-108. PubMed ID: 14752828
[TBL] [Abstract][Full Text] [Related]
19. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.
Chou CF; Hsieh YH; Grubbs CJ; Atigadda VR; Mobley JA; Dummer R; Muccio DD; Eto I; Elmets CA; Garvey WT; Chang PL
J Dermatol Sci; 2018 Jun; 90(3):343-356. PubMed ID: 29599065
[TBL] [Abstract][Full Text] [Related]
20. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells.
Kooistra T; Lansink M; Arts J; Sitter T; Toet K
Eur J Biochem; 1995 Sep; 232(2):425-32. PubMed ID: 7556191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
